Research Article
Lack of Association between Pulse Steroid Therapy and Bone Mineral Density in Patients with Multiple Sclerosis
Table 1
Descriptive characteristics of MS patients and controls (mean ± SD or count).
| | | MS patients | Controls | |
| | Sex (female/male) | 155 (104/51) | 90 (58/32) | 0.66 | | Age, all | 35.6 ± 9.3 | 36.6 ± 8.5 | 0.36 | | Female | 35.1 ± 9.1 | 37.7 ± 8.2 | 0.07 | | Male | 36.7 ± 9.8 | 34.6 ± 8.7 | 0.32 | | Smoking years | 10.7 ± 9.8 | 10.2 ± 9.4 | 0.44 | | Body mass index (kg/m2) | 23.6 ± 3.2 | 24.1 ± 3.1 | 0.37 | | Mean age at onset | 27.7 ± 8.1 | | | | MS duration (years) | 7.7 ± 5.8 | | | | Relapse number | 3.8 ± 2.9 | | | | EDSS | 2.6 ± 2.0 | | | | Total steroid dose (gram) | 13.9 ± 13.4 | | | | 25(OH)D (ng/mL) | 12.4 ± 7.1 | | | | RRMS/SPMS/PPMS% | 71/26/7 | | |
|
|
SD: standard deviation; RRMS: relapsing-remitting multiple sclerosis; SPMS: secondary progressive multiple sclerosis; PPMS: primary progressive multiple sclerosis.
|
